EOG
56
-2
CMS
60
2
XRX
41
6
BXP
52
2
M
25
5
NRG
52
3
BA
49
-3
LEN
52
2
PDCO
38
3
PBI
65
5
EQIX
62
2
DHI
44
-4
XYL
45
8
AMAT
42
6
KIM
76
2
EMC
53
5
BMY
58
5
SEE
52
6
GIS
28
2
AKAM
50
7
EOG
56
-2
CMS
60
2
XRX
41
6
BXP
52
2
M
25
5
NRG
52
3
BA
49
-3
LEN
52
2
PDCO
38
3
PBI
65
5
EQIX
62
2
DHI
44
-4
XYL
45
8
AMAT
42
6
KIM
76
2
EMC
53
5
BMY
58
5
SEE
52
6
GIS
28
2
AKAM
50
7
Financhill
Back

PTC Therapeutics Stock Price Chart

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35

PTCT
PTC Therapeutics

Last Price:
42.92
Seasonality Move:
23.53%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTC Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 41.72 Buy
20-day SMA: 41.76 Buy
50-day SMA: 39.03 Buy
200-day SMA: 33.46 Buy
8-day EMA: 41.65 Buy
20-day EMA: 41.33 Buy
50-day EMA: 39.38 Buy
200-day EMA: 35.07 Buy

PTC Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.71 Buy
Relative Strength Index (14 RSI): 57.17 Buy
Chaikin Money Flow: 315890 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.56 - 43.3) Buy
Bollinger Bands (100): (32.11 - 39.83) Buy

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for PTC Therapeutics Stock

Is PTC Therapeutics Stock a Buy?

  • PTC Therapeutics share price is 42.89 while PTCT 8-day simple moving average is 41.72, which is a Buy signal.
  • The stock price of PTCT is 42.89 while PTC Therapeutics 20-day SMA is 41.76, which makes it a Buy.
  • PTC Therapeutics 50-day simple moving average is 39.03 while PTCT share price is 42.89, making it a Buy technically.
  • PTCT stock price is 42.89 and PTC Therapeutics 200-day simple moving average is 33.46, creating a Buy signal.

PTCT Technical Analysis vs Fundamental Analysis

Sell
35
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy or a Sell?

  • PTC Therapeutics stock is rated a Sell
    The current PTC Therapeutics [PTCT] share price is $42.89. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.

PTC Therapeutics Stock Info

Market Cap:
3.31B
Price in USD:
42.89
Share Volume:
599.1K

PTC Therapeutics 52-Week Range

52-Week High:
46.98
52-Week Low:
20.75
Sell
35
PTC Therapeutics (PTCT) is a Sell

PTC Therapeutics Share Price Forecast

Is PTC Therapeutics Stock a Buy?

  • PTC Therapeutics share price is 42.89 while PTCT 8-day exponential moving average is 41.65, which is a Buy signal.
  • The stock price of PTCT is 42.89 while PTC Therapeutics 20-day EMA is 41.33, which makes it a Buy.
  • PTC Therapeutics 50-day exponential moving average is 39.38 while PTCT share price is 42.89, making it a Buy technically.
  • PTCT stock price is 42.89 and PTC Therapeutics 200-day simple moving average is 35.07, creating a Buy signal.

Fundamental Analysis of PTC Therapeutics

Is PTC Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $1.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $0.55 per share.

Technical Analysis of PTC Therapeutics

Should I short PTC Therapeutics stock?

* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.